Vancomycin-associated acute kidney injury in Hong Kong in 2012–2016

Autor: Xuzhen Qin, Man-Fung Tsoi, Xinyu Zhao, Lin Zhang, Zhihong Qi, Bernard M. Y. Cheung
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: BMC Nephrology, Vol 21, Iss 1, Pp 1-9 (2020)
Druh dokumentu: article
ISSN: 1471-2369
DOI: 10.1186/s12882-020-1704-4
Popis: Abstract Background To study the incidence of vancomycin-associated acute kidney injury (VA-AKI) in Hong Kong and identify risk factors for VA-AKI. Method Patients with vancomycin prescription and blood level measurement in 2012–2016 were identified using the Hong Kong Hospital Authority Clinical Data Analysis and Reporting System. Acute kidney injury was defined using KDIGO criteria. Patients without creatinine measurements, steady-state trough vancomycin level or who had vancomycin treatment 60 and newborn and infants, respectively. Baseline creatinine, serum trough vancomycin level, systematic disease history including respiratory failure, hypertension, congestive heart failure, chronic renal failure, anemia and type II diabetes, and concomitant diuretics, piperacillin-tazobactam (PTZ) and meropenem prescription were significantly higher in VA-AKI patients older than 12 years. Logistic regression showed that older age group, higher baseline creatinine, serum trough vancomycin level, respiratory failure, chronic renal failure and congestive heart failure, concomitant diuretics, PTZ and meropenem prescription, and longer hospital stay were all associated with increased risk of VA-AKI. Conclusion The incidence of VA-AKI in Hong Kong is low but shows no decline. Patients with higher baseline creatinine, multi-organ diseases and multiple drugs administration should have their vancomycin level monitored to decrease the risk of VA-AKI.
Databáze: Directory of Open Access Journals